Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 27

1.

Immunization with hybrid recombinant Mycobacterium tuberculosis H37Rv proteins increases the TH1 cytokine response in mice following a pulmonary instillation of irradiated mycobacteria.

Walton CB, Inos AB, Andres OA, Jube S, de Couet HG, Douglas JT, Patek PQ, Borthakur D.

Vaccine. 2008 Aug 12;26(34):4396-402. doi: 10.1016/j.vaccine.2008.05.093. Epub 2008 Jun 26.

PMID:
18585419
3.

Detergent and enzyme treatment of apoptotic cells for the observation of DNA fragmentation.

Park DJ, Patek PQ.

Biotechniques. 1998 Apr;24(4):558-60. No abstract available.

4.

The involvement of protein tyrosine kinase activity in a tumor necrosis factor resistance mechanism.

Sasaki CY, Patek PQ.

Proc Soc Exp Biol Med. 1995 Oct;210(1):25-32.

PMID:
7675795
5.
6.

Inhibition of tumor necrosis factor-mediated lysis by spleen cell-conditioned medium.

Sasaki CY, Patek PQ.

Int J Immunopharmacol. 1994 Apr;16(4):301-9.

PMID:
8045670
8.
9.
10.
11.

Tumor surveillance revisited: natural cytotoxic (NC) activity deters tumorigenesis.

Patek PQ, Collins JL.

Cell Immunol. 1988 Oct 1;116(1):240-9. No abstract available.

PMID:
3167987
13.

Humans express natural cytotoxic (NC) cell activity that is similar to murine NC cell activity.

Collins JL, Kao MS, Patek PQ.

J Immunol. 1987 Jun 15;138(12):4180-4.

PMID:
3584975
14.

Natural cytotoxic cells and tumor necrosis factor activate similar lytic mechanisms.

Patek PQ, Lin Y, Collins JL.

J Immunol. 1987 Mar 1;138(5):1641-6.

PMID:
3805728
15.

The cloned cell line L10A2.J expresses natural cytotoxic activity.

Collins JL, Patek PQ, Lin Y, Cohn M.

Cell Immunol. 1986 Nov;103(1):191-8.

PMID:
3492283
16.

Dissociation of contact-noninhibition in vitro and tumorigenicity in vivo.

Collins JL, Lin Y, Patek PQ.

Cell Biol Int Rep. 1986 Oct;10(10):789-96.

PMID:
2430726
17.
18.

Analysis of immune surveillance of sequentially derived cell lines that differ in their tumorigenic potential.

Lin Y, Patek PQ, Collins JL, Cohn M.

J Natl Cancer Inst. 1985 May;74(5):1025-30.

PMID:
3873568
19.
20.
21.

In vivo surveillance of tumorigenic cells transformed in vitro.

Collins JL, Patek PQ, Cohn M.

Nature. 1982 Sep 9;299(5879):169-71.

PMID:
7110338
22.

Activity and dexamethasone sensitivity of natural cytotoxic cell subpopulations.

Patek PQ, Collins JL, Cohn M.

Cell Immunol. 1982 Sep 1;72(1):113-21. No abstract available.

PMID:
7172243
23.

Tumorigenicity and lysis by natural killers.

Collins JL, Patek PQ, Cohn M.

J Exp Med. 1981 Jan 1;153(1):89-106.

24.

Cancer: a problem in somatic cell evolution.

Collins JL, Patek PQ, Cohn M.

Contemp Top Immunobiol. 1980;11:1-79. Review. No abstract available.

PMID:
6160946
25.

Anti-tumor potential of retinoic acid: stimulation of immune mediated effectors.

Patek PQ, Collins JL, Yogeeswaran G, Dennert G.

Int J Cancer. 1979 Nov 15;24(5):624-8.

PMID:
528077
26.

Transformed cell lines susceptible or resistant to in vivo surveillance against tumorigenesis.

Patek PQ, Collins JL, Cohn M.

Nature. 1978 Nov 30;276(5687):510-1. No abstract available.

PMID:
723934
27.

Postnatal development of the rat mandible.

Bernick S, Patek PQ.

J Dent Res. 1969 Nov-Dec;48(6):1258-63. No abstract available.

PMID:
5262056

Supplemental Content

Loading ...
Support Center